Tag: photodynamic therapy market forecast

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Photodynamic Therapy Market?

In recent times, the photodynamic therapy market has experienced a remarkable expansion. The market, which is predicted to increase from $1.45 billion in 2024 to $1.53 billion in 2025, has a compound annual growth rate (CAGR) of 5.6%. The grow during the historic period is due to multiple factors. These include the growing number of older adults, a rise in cancer cases, an upsurge in skin diseases, increasing rates of pollution, a surge in healthcare spending, and the expansion of healthcare facilities.

Expectations for the photodynamic therapy market predict substantial growth in the coming years, projected to reach “$1.93 billion in 2029 at a 6.0% compound annual growth rate (CAGR). This growth during the projected timeframe can be credited to factors such as increased healthcare spending, photodynamic therapy insurance coverage, untapped potential in developing economies, growing teenage and elderly populations, a rise in cancer and chronic disease prevalence, and the emerging threat of infectious diseases. Key emerging trends during this period are anticipated to include the launch of portable devices for home-based dermatological photodynamic therapy, investment in AI-powered photodynamic therapy to enhance patient outcomes, broadening of the product range for cosmetic procedures, ongoing funding for research and development, distribution of photoimmunotherapy devices and the inclusion of photothermal therapy in the product line-up.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Growth Drivers Are Shaping The Photodynamic Therapy Market Outlook?

The photodynamic therapy market is witnessing expansion due to the escalating incidence of skin cancer. Skin cancer tops the list of the most frequent forms of cancer. Despite accounting for just 1% of skin cancers, melanoma is responsible for a significant proportion of fatalities related to skin cancer. Photodynamic therapy (PDT) which incorporates a light-sensitizing medicine and high-intensity light to eliminate cancer cells, is used in response to this. By applying a lotion containing a chemical that sensitizes light onto the skin cancer along with the neighbouring area, doctors take action against this malady. Illustratively, data from the American Cancer Society in January 2024, a professional entity based in the U.S., indicated that skin cancer is the most common type of cancer there, with melanoma making up about 1% of cases but causing most skin cancer-related deaths. Furthermore, in 2024, it is estimated that around 100,640 fresh melanoma instances will be detected in the U.S, which comprises approximately 59,170 men and 41,470 women. An estimated 8,290 individuals, including roughly 5,430 males and 2,860 females, are predicted to die from melanoma. Hence, the growing prevalence of skin cancer is anticipated to boost the photodynamic therapy market’s growth in the forthcoming years.

Which Segments Define The Structure Of The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Strategic Shifts And Innovations Are Influencing The Photodynamic Therapy Market?

In the industry of photodynamic therapy, an increased focus has been observed on clinical trials for PDT in tandem with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, declared the initiation of a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. With the clinical trial labeled NCT05374915, it’s an open-label study, working with 15 patients having cutaneous metastatic breast cancer (CMBC). The trial is set to evaluate the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The aim of the trial is to perfect the study structure for a forthcoming Phase 3 trial and to focus on the Best Overall Objective Response Rate (bORR) within treatment areas within the span of 24 weeks. The chief endpoint comprises both complete and partial responses measurement.

Which Firms Are Making The Biggest Impact In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Forecasted To Lead The Photodynamic Therapy Market In The Coming Years?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Photodynamic Therapy Market From 2025 to 2029?

Recent years have seen a powerful surge in the market size of photodynamic therapy. The market is projected to expand from $1.45 billion in 2024 to $1.53 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.6%. Various factors have contributed to this growth during the historic period, including a growing aging population, the surge in cancer cases, an upswing in skin diseases, escalating pollution levels, an enhancement in healthcare expenditure, and an increase in the number of healthcare facilities.

The photodynamic therapy market is projected to experience robust growth in the coming years, reaching a value of “$1.93 billion by 2029 with a compound annual growth rate (CAGR) of 6.0%.” The forecast period’s expansion is linked to factors like increased healthcare spending, insurance plans covering photodynamic therapy, untapped potential in developing economies, growing teenage and elderly demographics, a surge in cancer and chronic disease cases, and the emergence of infectious diseases. Key trends during this period are expected to include the launch of portable photodynamic therapy devices for at-home skin PDT treatments, investment in AI-driven PDT to enhance patient care, expanding product range in the cosmetic procedure sector, sustained investment in research and development, and an emphasis on introducing photoimmunotherapy devices and including photothermal therapy in the portfolio.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Elements Are Contributing To Growth In The Photodynamic Therapy Market?

The escalating occurrence of skin cancer is instrumental in driving the growth of the market for photodynamic therapy. Skin cancer is noted as the most prevalent amongst all forms of cancer. Melanoma, although constituting approximately just 1% of skin cancers, is associated with a significant number of skin cancer fatalities. Photodynamic therapy (PDT) leverages a light-sensitizing medication and intensive light to eradicate cancerous cells. The practitioner applies a lotion containing a light-sensitizing chemical to the skin cancer and the vicinity surrounding it. For example, in January 2024, the American Cancer Society, a professional organization based in the US, stated that skin cancer is the primary cancer in the US, with melanoma accounting for around 1% of cases, but responsible for most skin cancer deaths. Additionally, around 100,640 novel melanoma cases are anticipated to be diagnosed in 2024 in the US, of which roughly 59,170 are expected in men and 41,470 in women. Approximately 8,290 melanoma-associated deaths are also projected, which include around 5,430 men and 2,860 women. Consequently, the rising rates of skin cancer are foreseen to stimulate the growth of the photodynamic therapy market in the future years.

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Notable Trends Are Shaping The Direction Of The Photodynamic Therapy Market?

The photodynamic therapy market’s participants are paying increasing attention to clinical trials involving various drug combinations for PDT. Kintara Therapeutics, a biotech company based in the US, for instance, kick-started a clinical trial for their REM-001 therapy, aimed at cutaneous metastatic breast cancer, in February 2024. The clinical trial, NCT05374915, is an open-label study with 15 participants suffering from cutaneous metastatic breast cancer (CMBC). The trial, which evaluates the second-generation photodynamic therapy agent REM-001 with a dosage of 0.8 mg, is designed to enhance the study setup before a Phase 3 trial. The main focus is on the Best Overall Objective Response Rate (bORR) in the treatment areas within 24 weeks and the primary endpoint revolves around the measurement of complete and partial responses.

Who Are The Key Contributors To Growth In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Projected To Lead The Photodynamic Therapy Market By 2025?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Photodynamic Therapy Market Size from 2025 to 2034?

There has been significant growth in the photodynamic therapy market size in the past few years. The market, which was valued at $1.45 billion in 2024, is projected to increase to $1.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include a rise in the aging population, an uptick in cancer incidence and skin disorders, escalating pollution levels, higher spending on healthcare, and an expansion in the number of healthcare establishments.

In the coming years, there is anticipated vigorous expansion in the market for photodynamic therapy, which is projected to reach $1.93 billion in 2029, flourishing at a compounded annual growth rate (CAGR) of 6.0%. The predicted increase during this period can be credited to factors such as expanding healthcare investment, coverage of photodynamic therapy by insurance, promising opportunities in developing economies, a surge in the adolescent and aged demographic, an escalated incidence of cancer and chronic disorders, and the advent of contagious diseases. The noteworthy trends for the forecasted tenure are the launching of portable devices for photodynamic therapy that aid in conducting dermatological PDT procedures at home, channeling funds into AI-powered PDT to better patient treatment, broadening the product spectrum in the realm of cosmetic treatments, ongoing funding for research and development, and striving to offer photoimmunotherapy devices besides augmenting the portfolio to incorporate photothermal therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Photodynamic Therapy Market?

The surge in skin cancer incidences is propelling the photodynamic therapy market. Skin cancer happens to be the most prevalent type of cancer. Even though melanoma accounts for only about 1% of skin cancers, it’s responsible for a significant number of skin cancer fatalities. Photodynamic therapy (PDT) employs a combination of a photosensitizing drug and a high-intensity light source to eradicate cancer cells. In this process, a lotion containing a photosensitizing chemical is applied by the physician to the skin cancer as well as the nearby area. For instance, the American Cancer Society, a renowned US organization, stated in January 2024 that skin cancer is the most frequently observed cancer in the U.S., with melanoma accounting for 1% of the cases but leading to most skin cancer deaths. Furthermore, in 2024, an expected 100,640 fresh melanoma cases will be identified in the U.S., including approximately 59,170 men and 41,470 women. About 8,290 fatalities from melanoma are foreseen, with approximately 5,430 men and 2,860 women among them. Thus, the escalating prevalence of skin cancer is projected to boost the photodynamic therapy market in future years.

Which Key Market Segments Comprise the Photodynamic Therapy Market and Drive Its Revenue Growth?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Which Areas Are Leading Regions in the Photodynamic Therapy Market Expansion Across the Globe?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePhotodynamic Therapy Market Over the Coming Years?

Industry participants in the photodynamic therapy market are increasingly directing their efforts towards clinical trials that integrate PDT with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, initiated a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. The open-label study NCT05374915, which encompasses 15 patients suffering from cutaneous metastatic breast cancer (CMBC), tests the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial’s objective is to refine the study design in anticipation of a Phase 3 trial and to concentrate on the Best Overall Objective Response Rate (bORR) within the treatment fields over a span of 24 weeks. The primary endpoint includes the measure of entire and partial responses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is the Photodynamic Therapy Market Conceptually Defined?

Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Photodynamic Therapy Market Size from 2025 to 2034?

There has been significant growth in the photodynamic therapy market size in the past few years. The market, which was valued at $1.45 billion in 2024, is projected to increase to $1.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include a rise in the aging population, an uptick in cancer incidence and skin disorders, escalating pollution levels, higher spending on healthcare, and an expansion in the number of healthcare establishments.

In the coming years, there is anticipated vigorous expansion in the market for photodynamic therapy, which is projected to reach $1.93 billion in 2029, flourishing at a compounded annual growth rate (CAGR) of 6.0%. The predicted increase during this period can be credited to factors such as expanding healthcare investment, coverage of photodynamic therapy by insurance, promising opportunities in developing economies, a surge in the adolescent and aged demographic, an escalated incidence of cancer and chronic disorders, and the advent of contagious diseases. The noteworthy trends for the forecasted tenure are the launching of portable devices for photodynamic therapy that aid in conducting dermatological PDT procedures at home, channeling funds into AI-powered PDT to better patient treatment, broadening the product spectrum in the realm of cosmetic treatments, ongoing funding for research and development, and striving to offer photoimmunotherapy devices besides augmenting the portfolio to incorporate photothermal therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Photodynamic Therapy Market?

The surge in skin cancer incidences is propelling the photodynamic therapy market. Skin cancer happens to be the most prevalent type of cancer. Even though melanoma accounts for only about 1% of skin cancers, it’s responsible for a significant number of skin cancer fatalities. Photodynamic therapy (PDT) employs a combination of a photosensitizing drug and a high-intensity light source to eradicate cancer cells. In this process, a lotion containing a photosensitizing chemical is applied by the physician to the skin cancer as well as the nearby area. For instance, the American Cancer Society, a renowned US organization, stated in January 2024 that skin cancer is the most frequently observed cancer in the U.S., with melanoma accounting for 1% of the cases but leading to most skin cancer deaths. Furthermore, in 2024, an expected 100,640 fresh melanoma cases will be identified in the U.S., including approximately 59,170 men and 41,470 women. About 8,290 fatalities from melanoma are foreseen, with approximately 5,430 men and 2,860 women among them. Thus, the escalating prevalence of skin cancer is projected to boost the photodynamic therapy market in future years.

Which Key Market Segments Comprise the Photodynamic Therapy Market and Drive Its Revenue Growth?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Which Areas Are Leading Regions in the Photodynamic Therapy Market Expansion Across the Globe?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePhotodynamic Therapy Market Over the Coming Years?

Industry participants in the photodynamic therapy market are increasingly directing their efforts towards clinical trials that integrate PDT with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, initiated a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. The open-label study NCT05374915, which encompasses 15 patients suffering from cutaneous metastatic breast cancer (CMBC), tests the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial’s objective is to refine the study design in anticipation of a Phase 3 trial and to concentrate on the Best Overall Objective Response Rate (bORR) within the treatment fields over a span of 24 weeks. The primary endpoint includes the measure of entire and partial responses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is the Photodynamic Therapy Market Conceptually Defined?

Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Projected CAGR for the Photodynamic Therapy Market Size from 2025 to 2034?#_x000D_

There has been significant growth in the photodynamic therapy market size in the past few years. The market, which was valued at $1.45 billion in 2024, is projected to increase to $1.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to the growth during the historic period include a rise in the aging population, an uptick in cancer incidence and skin disorders, escalating pollution levels, higher spending on healthcare, and an expansion in the number of healthcare establishments._x000D_

_x000D_

In the coming years, there is anticipated vigorous expansion in the market for photodynamic therapy, which is projected to reach $1.93 billion in 2029, flourishing at a compounded annual growth rate (CAGR) of 6.0%. The predicted increase during this period can be credited to factors such as expanding healthcare investment, coverage of photodynamic therapy by insurance, promising opportunities in developing economies, a surge in the adolescent and aged demographic, an escalated incidence of cancer and chronic disorders, and the advent of contagious diseases. The noteworthy trends for the forecasted tenure are the launching of portable devices for photodynamic therapy that aid in conducting dermatological PDT procedures at home, channeling funds into AI-powered PDT to better patient treatment, broadening the product spectrum in the realm of cosmetic treatments, ongoing funding for research and development, and striving to offer photoimmunotherapy devices besides augmenting the portfolio to incorporate photothermal therapy._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Photodynamic Therapy Market?#_x000D_

The surge in skin cancer incidences is propelling the photodynamic therapy market. Skin cancer happens to be the most prevalent type of cancer. Even though melanoma accounts for only about 1% of skin cancers, it’s responsible for a significant number of skin cancer fatalities. Photodynamic therapy (PDT) employs a combination of a photosensitizing drug and a high-intensity light source to eradicate cancer cells. In this process, a lotion containing a photosensitizing chemical is applied by the physician to the skin cancer as well as the nearby area. For instance, the American Cancer Society, a renowned US organization, stated in January 2024 that skin cancer is the most frequently observed cancer in the U.S., with melanoma accounting for 1% of the cases but leading to most skin cancer deaths. Furthermore, in 2024, an expected 100,640 fresh melanoma cases will be identified in the U.S., including approximately 59,170 men and 41,470 women. About 8,290 fatalities from melanoma are foreseen, with approximately 5,430 men and 2,860 women among them. Thus, the escalating prevalence of skin cancer is projected to boost the photodynamic therapy market in future years._x000D_

_x000D_

#Which Key Market Segments Comprise the Photodynamic Therapy Market and Drive Its Revenue Growth?#_x000D_

The photodynamic therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Drugs, Devices_x000D_

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications_x000D_

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations_x000D_

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems) _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Photodynamic Therapy Market Expansion Across the Globe?#_x000D_

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Key Market Trends in thePhotodynamic Therapy Market Over the Coming Years?#_x000D_

Industry participants in the photodynamic therapy market are increasingly directing their efforts towards clinical trials that integrate PDT with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, initiated a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. The open-label study NCT05374915, which encompasses 15 patients suffering from cutaneous metastatic breast cancer (CMBC), tests the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial’s objective is to refine the study design in anticipation of a Phase 3 trial and to concentrate on the Best Overall Objective Response Rate (bORR) within the treatment fields over a span of 24 weeks. The primary endpoint includes the measure of entire and partial responses._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report_x000D_

_x000D_

#How Is the Photodynamic Therapy Market Conceptually Defined?#_x000D_

Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Photodynamic Therapy Market Growth in 2025?

The market size for photodynamic therapy has experienced significant growth in the past few years. There is an expected growth from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. Factors such as an expanding elderly population, rising cases of cancer and skin diseases, an increase in pollution levels, higher healthcare spending, and an increase in the number of healthcare centers have contributed to the historical growth.

What Is the Forecast for the Photodynamic Therapy Market Size Through 2029?

In the coming years, it is anticipated that the photodynamic therapy market will experience robust growth. The prediction is that by 2029, the value of this market will reach $2 billion, with a compound annual growth rate (CAGR) of 6.5%. The increased expansion anticipated over the forecast period stems from factors such as escalating healthcare expenditure, photodynamic therapy insurance coverage, the high potential seen in emerging economies, the growing teenage demographic, the amplifying older population, the rising occurrence of cancer and chronic conditions, and the emergence of infectious diseases. Significant trends during the forecast period include the advent of portable photodynamic therapy devices for at-home dermatological PDT treatments, investment in PDT powered by artificial intelligence for enhanced patient treatment, expansion of the product range in cosmetic procedures, ongoing investment in R&D, and efforts to offer photoimmunotherapy devices and extend the product range to incorporate photothermal therapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What are the Key Market Players in Photodynamic Therapy Market and How They’re Evolving?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

What Are the Primary Growth Drivers in the Photodynamic Therapy Market?

The growth of the photodynamic therapy market can be attributed to the escalating incidences of skin cancer, which is the most common form of all types of cancer. Despite only constituting about 1% of skin cancer types, Melanoma is responsible for a significant amount of deaths related to skin cancer. Photodynamic treatment (PDT), a method that utilizes a powerful light and light-sensitizing drug together to kill cancer cells, is gaining popularity. The treatment involves applying a lotion that contains a light-sensitizing chemical to the area affected by the skin cancer. As reported by the American Cancer Society in January 2024, skin cancer has the highest incidence in the U.S., with Melanoma accounting for 1% of cases and a majority of skin cancer-related deaths. Moreover, in 2024, the biggest cases of melanoma in the country are anticipated to reach 100,640 with about 59,170 affecting men and 41,470 affecting women. Predicted melanoma deaths are about 8,290, including around 5,430 among men and 2,860 among women. As a result, the rising occurrence of skin cancer is set to drive the photodynamic therapy market in the following years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

What Are the Leading Segments in the Global Photodynamic Therapy Industry?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Are the Key Market Trends in the Photodynamic Therapy Industry?

An increasing number of entities within the photodynamic therapy market are showing a growing interest in conducting clinical trials that combine PDT with various pharmaceuticals. For instance, US-based biotech firm Kintara Therapeutics, in February 2024, revealed the commencement of a clinical trial for their REM-001 therapy that targets cutaneous metastatic breast cancer. The open-label study, identified by NCT05374915, involves 15 cutaneous metastatic breast cancer (CMBC) patients and aims to assess the effectiveness of the second-generation photodynamic therapy agent REM-001 in a 0.8 mg dosage. This trial aims to finetune the study design in preparation for a Phase 3 trial and primarily focuses on the bORR in treatment fields within a 24-week scope. The primary outcome measure will be the evaluation of complete and partial responses.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

What Is the Regional Outlook for the Photodynamic Therapy Market?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

This Report Delivers Insight On:

1. How big is the photodynamic therapy market, and how is it changing globally?

2. Who are the major companies in the photodynamic therapy market, and how are they performing?

3. What are the key opportunities and risks in the photodynamic therapy market right now?

4. Which products or customer segments are growing the most in the photodynamic therapy market?

5. What factors are helping or slowing down the growth of the photodynamic therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the photodynamic therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Photodynamic Therapy Market Growth Performance Trended Historically, And What Lies Ahead?

In recent times, the market size for photodynamic therapy has seen robust growth. There is projected growth from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The previous period’s growth can be linked to factors such as the rise in the aging population, a surge in cases of cancer, increased occurrences of skin diseases, burgeoning pollution levels, escalation in healthcare expenditures, and an increase in healthcare facilities.

Over the coming years, the photodynamic therapy market is projected to experience robust growth, reaching $2 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. Factors driving growth during this forecast period include an increase in medical spending, insurance that covers photodynamic therapy, great potential in burgeoning economies, a rise in the adolescent and senior populations, growing incidence of cancer and chronic illnesses, and the emergence of new infectious diseases. Noteworthy trends for the period include the launch of a mobile photodynamic therapy device for home-based dermatologic PDT treatments, investment in AI-integrated PDT for better patient care, extending the product range in cosmetic procedures, continued commitment in R&D, concentrating on offering photoimmunotherapy equipment and widening the collection to cover photothermal therapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What Are the Core Market Drivers Propelling Growth in the Photodynamic Therapy Industry?

The escalating incidence of skin cancer is bolstering the expansion of the photodynamic therapy market. It is noted that skin cancer is the most prevalent type among all others. Melanoma, while making up only around 1% of skin cancer incidents, attributes to a significant number of fatalities related to skin cancer. Photodynamic therapy (PDT) utilises a blend of a light-reactive drug and high-intensity light to annihilate cancer cells. A light-sensitive chemical-infused cream is applied by the doctor to the skin cancer area and the nearby region. To provide an example, the American Cancer Society stated in January 2024 that skin cancer is the most widespread cancer in the U.S, with melanoma making up approximately 1% of incidents but being accountable for the most fatalities caused by skin cancer. Furthermore, it’s estimated in 2024 that there will be 100,640 new melanoma diagnoses in the U.S, which will include roughly 59,170 men and 41,470 women. It’s projected that there will be around 8,290 melanoma-related fatalities, counting approximately 5,430 men and 2,860 women. Consequently, the accelerating incidence of skin cancer is anticipated to propel the progress of the photodynamic therapy market in the forthcoming years.

How Is the Photodynamic Therapy Market Segmented?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Which Regions Are Driving the Next Phase of the Photodynamic Therapy Market Growth?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Photodynamic Therapy Industry?

The photodynamic therapy market is witnessing a surge in clinical trials of PDT in conjunction with various drugs, led by market players. For instance, Kintara Therapeutics, a biotechnology firm based in the US, launched a clinical trial for its REM-001 treatment, specially designed for cutaneous metastatic breast cancer, in February 2024. The trial, labeled NCT05374915, is an open-label study that involves 15 patients diagnosed with cutaneous metastatic breast cancer (CMBC). It will evaluate the efficacy of the second-generation photodynamic therapy drug, REM-001, with a dosage of 0.8 mg. The focus of the study is to optimize the trial design for the upcoming Phase 3 trial and to assess the Best Overall Objective Response Rate (bORR) in specific treatment fields within a 24-week period. The main goal of the trial will be to measure both complete and partial responses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

How Is the Photodynamic Therapy Market Defined and What Are Its Core Parameters?

Photodynamic therapy refers to a procedure that uses a light source and medication that is light-sensitive to eliminate aberrant cells. Some eye and skin disorders, as well as specific cancers, can be treated with it. Photodynamic therapy (PDT) is a two-stage treatment that combines light energy with a drug (photosensitizer) designed to destroy cancerous and precancerous cells after light activation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of thePhotodynamic Therapy Market?

The growth of the photodynamic therapy market is being fueled by the increasing incidence of skin cancer, which is the most common cancer of all cancers. Melanoma only accounts for about 1% of skin cancer, but it is responsible for a significant number of fatalities. Photodynamic therapy (PDT), which uses a mixture of a light-activated drug and a high-intensity light to kill cancer cells, is becoming increasingly popular. A lotion containing a light-activated chemical is applied by a doctor to the skin cancer and its surrounding area. As per the American Cancer Society’s January 2024 report, skin cancer is the most widespread cancer in the U.S., with melanoma accounting for 1% of cases but causing most deaths related to skin cancer. Additionally, an estimated 100,640 new melanoma cases will be identified in the U.S. in 2024, of which roughly 59,170 will be men and 41,470 women. Furthermore, melanoma is expected to cause about 8,290 deaths, including about 5,430 men and 2,860 women. Thus, the escalating cases of skin cancer are anticipated to promote photodynamic therapy market growth in the future.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

What is the Predicted Annual Growth Rate of thePhotodynamic Therapy Market Impact Industry Trends by 2034?

The market size for photodynamic therapy has significantly expanded over recent years. The value is projected to rise from $1.45 billion in 2024 to $1.55 billion in 2025, presenting a compound annual growth rate (CAGR) of 7.0%. Various factors have contributed to the growth in the historic period, including a growing elderly population, a surge in cancer instances, an escalation in skin disease cases, a rise in pollution levels, increased spending on healthcare, and an expanded number of healthcare institutions.

The market for photodynamic therapy is projected to witness robust growth in the foreseeable future, with its value estimated to reach $2 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. This increment in the forecast period is ascribed to factors such as increased spending on health care, insurance coverage for photodynamic therapy, high growth potential in developing economies, growing teenage and elderly population, rising cases of cancer and chronic diseases, and the emergence of infectious diseases. Key trends during the forecast period include the launch of a portable device for photodynamic therapy enabling at-home dermatological PDT treatments, capital investments in AI-enhanced PDT for better patient treatment, diversification in the cosmetic procedures product range, sustained investment in R&D, and attempts to provide photoimmunotherapy devices and widen the product range to incorporate photothermal therapy.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

What Are the Latest Innovations Influencing thePhotodynamic Therapy Market?

The photodynamic therapy market’s entities are putting forth greater efforts towards clinical trials of PDT combined with various drugs. An example of this occurred in February 2024 when Kintara Therapeutics, a biotechnology firm based in the US, commenced a clinical trial for their REM-001 therapy, which focuses on cutaneous metastatic breast cancer. Involving 15 patients with CMBC, this open-label study (clinical trial NCT05374915) assesses the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The aim of this trial is prioritizing the optimization of the study’s design before proceeding to a Phase 3 trial and emphasizes the Best Overall Objective Response Rate (bORR) in treatment fields within a period of 24 weeks. The study’s main endpoint is the measurement of both complete and partial responses.

Who Are the Major Industry Players Accelerating Growth in thePhotodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Primary Segments of the Photodynamic Therapy Market Are Driving Growth and Industry Transformations?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of thePhotodynamic Therapy Market?# Market?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Photodynamic Therapy Market 2025, By The Business Research Company:

Liquid Fertilizers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liquid-fertilizers-global-market-report

Fertilizer Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertilizer-additives-global-market-report

Nitrogenous Fertilizer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nitrogenous-fertilizer-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the photodynamic therapy market grown in recent years?

The market for photodynamic therapy has experienced robust expansion in the past few years. It is anticipated to escalate from $1.45 billion in 2024 to $1.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 7.0%. The substantial growth observed in the historical period is the result of factors such as the growth in the elderly population, the surge in cancer cases, a rise in skin ailments, increasing pollution levels, greater spending on healthcare, and an increase in the number of healthcare institutions.

How is the photodynamic therapy market size expected to evolve during the forecast period?

The market size of metals and minerals is projected to experience a steady rise in the coming years. By 2029, the market is anticipated to reach $10704.96 billion, with a compound annual growth rate (CAGR) of 4.6%. Various factors contributing to the growth during the projected period include the implementation of circular economy strategies, the electric vehicle (EV) revolution, resilience in the supply chain, geopolitical elements, and shifting consumer preferences. Noteworthy trends expected during this period encompass green technology, innovative processing technology, advances in mining technology, a heightened emphasis on recycling, and incorporation of digitalization and automation in mining practices.

Get your photodynamic therapy market report here!

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which key drivers are propelling the photodynamic therapy market’s growth?

The escalating incidence of skin cancer is a key factor driving the expansion of the photodynamic therapy market. Skin cancer is noted to be the most frequently occurring type of all cancers. Even though melanoma only accounts for around 1% of skin cancers, it results in a significant number of skin cancer fatalities. Photodynamic therapy (PDT) employs a mix of light-sensitive drug and intense light to kill cancer cells. In this method, a lotion infused with a light-sensitive chemical is applied to the skin cancer and the surrounding region. As per the American Cancer Society in January 2024, skin cancer tops the list of most common cancers in the U.S., with melanoma making up roughly 1% of the total cases but causing most skin cancer-related deaths. Furthermore, it is estimated that in 2024, around 100,640 new melanoma cases will be reported in the U.S., with approximately 59,170 in men and 41,470 in women. About 8,290 melanoma-related deaths are anticipated, including roughly 5,430 men and 2,860 women. Thus, the rising incidence of skin cancer is likely to stimulate the expansion of the photodynamic therapy market in the forthcoming years.

What are the market segments in the photodynamic therapy industry?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which leading companies are shaping the growth of the photodynamic therapy market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

What key trends are currently impacting the photodynamic therapy market’s development?

Companies operating within the photodynamic therapy market are directing their efforts towards clinical research, particularly trials that combine PDT with various medicines. An example of this trend was seen in February 2024 when Kintara Therapeutics, a biotechnology firm based in the United States, declared the start of a new clinical trial for their treatment, REM-001, designed specifically for cutaneous metastatic breast cancer. The trial in question, NCT05374915, is an open-label study involving 15 CMBC patients, testing the efficiency of the second-generation photodynamic treatment agent REM-001 at 0.8 mg dose. The goal of the trial is to enhance the design of the study in preparation for a Phase 3 trial, focusing on the Best Overall Objective Response Rate (bORR) in treatment areas within a 24-week period. The primary goal of the study is to evaluate complete and partial responses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5246

Which geographic areas are influencing the growth of the photodynamic therapy market?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pain Management Devices And Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Wound Care Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: